Search research articles
Contact Us
Filters
Showing results (51-60 of 88) with videos related to
Page
of 9
Sort By:
International Journal of Oncology
|
May 20, 2021
Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival
Maëva Chauvin, Véronique Garambois, Sylvie Choblet, et al.
Cancers
|
April 3, 2021
Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study
Martinez Alejandra, Witold Gertych, Christophe Pomel, et al.
Oncotarget
|
September 13, 2014
HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models
Gaëlle Thomas, Thierry Chardès, Nadège Gaborit, et al.
Mabs
|
April 20, 2021
Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models
Emilia Rabia, Véronique Garambois, Julie Hubert, et al.
Clinics and Research in Hepatology and Gastroenterology
|
September 24, 2019
Outcome after pancreatectomy for neuroendocrine neoplams according to the WHO 2017 grading system: A retrospective multicentric analysis of 138 consecutive patients
Regis Souche, Antoine Coignac, Marie Dupuy, et al.
Cancer Letters
|
June 24, 2018
Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer
Charline Ogier, Pierre-Emmanuel Colombo, Corinne Bousquet, et al.
Frontiers in Oncology
|
March 31, 2022
Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study
Morgan Michalet, Karl Bordeau, Marie Cantaloube, et al.
Cancers
|
October 16, 2024
Eligibility for Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in Endocrine Receptor-Positive and HER2-Negative Early Breast Cancer by Age and Type of Surgery
Gilles Houvenaeghel, Jean-Marc Classe, Marie-Pierre Chauvet, et al.
Oncotarget
|
January 27, 2018
The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway
Emilie Laprevotte, Stéphanie Cochaud, Stanislas du Manoir, et al.
Theranostics
|
November 28, 2022
The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases
Ambre Giguelay, Evgenia Turtoi, Lakhdar Khelaf, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 88) with videos related to
Sort By:
Page
of 9
International Journal of Oncology
|
May 20, 2021
Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival
Maëva Chauvin, Véronique Garambois, Sylvie Choblet, et al.
Cancers
|
April 3, 2021
Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study
Martinez Alejandra, Witold Gertych, Christophe Pomel, et al.
Oncotarget
|
September 13, 2014
HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models
Gaëlle Thomas, Thierry Chardès, Nadège Gaborit, et al.
Mabs
|
April 20, 2021
Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models
Emilia Rabia, Véronique Garambois, Julie Hubert, et al.
Clinics and Research in Hepatology and Gastroenterology
|
September 24, 2019
Outcome after pancreatectomy for neuroendocrine neoplams according to the WHO 2017 grading system: A retrospective multicentric analysis of 138 consecutive patients
Regis Souche, Antoine Coignac, Marie Dupuy, et al.
Cancer Letters
|
June 24, 2018
Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer
Charline Ogier, Pierre-Emmanuel Colombo, Corinne Bousquet, et al.
Frontiers in Oncology
|
March 31, 2022
Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study
Morgan Michalet, Karl Bordeau, Marie Cantaloube, et al.
Cancers
|
October 16, 2024
Eligibility for Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in Endocrine Receptor-Positive and HER2-Negative Early Breast Cancer by Age and Type of Surgery
Gilles Houvenaeghel, Jean-Marc Classe, Marie-Pierre Chauvet, et al.
Oncotarget
|
January 27, 2018
The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway
Emilie Laprevotte, Stéphanie Cochaud, Stanislas du Manoir, et al.
Theranostics
|
November 28, 2022
The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases
Ambre Giguelay, Evgenia Turtoi, Lakhdar Khelaf, et al.
Page
of 9